Literature DB >> 29511955

Analysis of evolutionary rate of HIV-1 subtype B using blood donor samples in Japan.

Naoya Shinohara1, Chieko Matsumoto2, Keiji Matsubayashi2, Tadashi Nagai2, Masahiro Satake2.   

Abstract

There are few reports on HIV-1 intra-host evolutionary rate in asymptomatic treatment-naïve patients. Here, the HIV-1 intra-host evolutionary rate was estimated based on HIV-1 RNA sequences from plasma samples of blood donors in Japan. Blood donors were assumed to have received no treatment for and have no symptoms of HIV-1 infection because they were healthy, and declared no risky behaviors of HIV-1 infection on a self-reported questionnaire or interview followed by donation. HIV-1 RNA was obtained from 85 plasma samples from 36 blood donors who donated blood multiple times and were HIV-1-positive. The C2V3C3 region which encodes for a part of the envelope protein, and the V3 loop in the C2V3C3 region were analyzed by RT-PCR and direct sequencing, and the sequences were compared. The nucleotide substitution rate was calculated by linear regression. All HIV-1 samples analyzed were classified as subtype B. The mean nucleotide substitution rate in C2V3C3 was calculated to be 6.2 × 10-3-1.8 × 10-2/site/year (V3: 4.5 × 10-3-2.3 × 10-2/site/year). The mean non-synonymous substitution rate in C2V3C3 was calculated to be 5.2 × 10-3-1.7 × 10-2/site/year (V3: 4.5 × 10-3-2.1 × 10-2/site/year). The mean synonymous substitution rate in C2V3C3 was calculated to be 1.1 × 10-4-2.3 × 10-3/site/year (V3: 2.9 × 10-3/site/year). Among HIV-1 subtype B RNA-positive blood donors in Japan, the nucleotide substitution rate in C2V3C3 was estimated to be higher than that of reported cases using HIV-1 samples mainly obtained from AIDS patients. Compared to AIDS patients, immune responses against HIV-1 are probably more effective in HIV-1 RNA-positive blood donors. Consequently, immune pressure presumably promotes mutation of the virus genome.

Entities:  

Keywords:  Asymptomatic; Blood donor; C2V3C3 region in the env gene; HIV-1; Nucleotide substitution rate; Treatment-naïve

Mesh:

Substances:

Year:  2018        PMID: 29511955     DOI: 10.1007/s11262-018-1548-1

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  20 in total

1.  Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models.

Authors:  Diana Edo-Matas; Philippe Lemey; Jennifer A Tom; Cèlia Serna-Bolea; Agnes E van den Blink; Angélique B van 't Wout; Hanneke Schuitemaker; Marc A Suchard
Journal:  Mol Biol Evol       Date:  2010-12-06       Impact factor: 16.240

Review 2.  Molecular mechanisms of HIV latency.

Authors:  Daniele C Cary; Koh Fujinaga; B Matija Peterlin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

3.  Genetic Analysis of HIV-1 in Japan: a Comprehensive Analysis of Donated Blood.

Authors:  Chieko Matsumoto; Naoya Shinohara; Rieko Sobata; Shigeharu Uchida; Masahiro Satake; Kenji Tadokoro
Journal:  Jpn J Infect Dis       Date:  2016-06-30       Impact factor: 1.362

Review 4.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions.

Authors:  Beda Joos; Marek Fischer; Andreas Schweizer; Herbert Kuster; Jürg Böni; Joseph K Wong; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  J Infect Dis       Date:  2007-06-05       Impact factor: 5.226

6.  Intra-host evolutionary rates in HIV-1C env and gag during primary infection.

Authors:  Vlad Novitsky; Rui Wang; Raabya Rossenkhan; Sikhulile Moyo; M Essex
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

7.  Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics.

Authors:  Philippe Lemey; Sergei L Kosakovsky Pond; Alexei J Drummond; Oliver G Pybus; Beth Shapiro; Helena Barroso; Nuno Taveira; Andrew Rambaut
Journal:  PLoS Comput Biol       Date:  2007-01-02       Impact factor: 4.475

Review 8.  Genetic Consequences of Antiviral Therapy on HIV-1.

Authors:  Miguel Arenas
Journal:  Comput Math Methods Med       Date:  2015-06-10       Impact factor: 2.238

Review 9.  HIV-1 drug resistance and resistance testing.

Authors:  Dana S Clutter; Michael R Jordan; Silvia Bertagnolio; Robert W Shafer
Journal:  Infect Genet Evol       Date:  2016-08-29       Impact factor: 3.342

10.  Faster Adaptation in Smaller Populations: Counterintuitive Evolution of HIV during Childhood Infection.

Authors:  Jayna Raghwani; Samir Bhatt; Oliver G Pybus
Journal:  PLoS Comput Biol       Date:  2016-01-07       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.